Metastatic lung cancer is cancer that has spread to one or more different areas of the body. It’s an advanced form of cancer that may be harder to treat. About 50 percent of lung cancers have metastasized (spread) by the time the diagnosis is made. Early detection of this disease is difficult because people don’t usually develop symptoms until after lung cancer has metastasized.
Cancer starts with gene changes in a single cell or group of cells. Cancerous gene changes make a cell grow out of control, producing many copies of itself. When large numbers of identical cells build up in a single place, they form a tumor. The first tumor that forms in the body is called the primary tumor.
Cancer can often spread from the primary tumor to other parts of the body. This process is known as metastasis. Metastasis is also the name for a single tumor that is growing in a distant location from the primary tumor. Symptoms and signs of metastatic lung cancer can vary, depending on where the cancer has spread.
Cancer can metastasize from a primary tumor in the lung to faraway organs or tissues. When this metastasis happens, doctors still consider the distant tumors to be lung cancer. For example, lung cancer cells that spread to the brain are lung cancer, not brain cancer. The cells look and act like lung cancer cells and should be managed with lung cancer treatments.
Cancer cells may metastasize by moving through the bloodstream. Other times, they travel through the lymphatic system (a network of vessels, tissues, and organs that fight infection and eliminate waste). The process of metastasis occurs through several steps:
Cancer cells can die at any step along this process. However, over time, some cells will usually be successful at metastasizing.
Metastasis plays a major role in how a tumor is staged. Lung cancer staging is a system that describes how big tumors are and how far they have spread in the body.
Staging is important because it helps doctors recommend treatment options. For example, an early-stage tumor found in a single location in the lung can often be treated with surgery. Removing the tumor and nearby tissue may be enough to treat some cases of early-stage cancer.
However, people with metastatic lung cancer may have cancer cells spread throughout their bodies. In this case, doctors more often recommend systemic therapy (medication that travels throughout the bloodstream and reaches all parts of the body). Treatment of lung metastases may include chemotherapy, radiation therapy, targeted therapy or immunotherapy, or a combination of therapies.
Doctors also use staging information to estimate a person’s prognosis (outlook). Lung cancer is often staged with the TNM system, which stands for tumor, nodes, and metastasis. Using this staging system, doctors score cancer within three categories. The numbers in each of these categories can tell you more about the cancer:
Doctors use TNM staging to assign lung cancer an overall stage. Non-small cell lung cancer (NSCLC) is staged on a scale from 0 to 4. Cancer stages are sometimes written with Roman numerals, as stages I through IV. Metastatic NSCLC is stage 4 (stage IV), the most advanced lung cancer stage. Small cell lung cancer (SCLC) is divided into two stages — limited stage and extensive stage. Limited-stage cancers are located in one area of the chest, and extensive-stage cancers are metastatic.
Doctors look for lung cancer metastases using imaging tests. These tests may include computed tomography (CT scans) or magnetic resonance imaging (MRI). Imaging tests can detect cancer cells throughout the body.
Lung cancer may spread to other organs or tissues. The most common sites for lung cancer metastases are the bone, brain, adrenal glands, liver, and distant lymph nodes. Lung cancer can also metastasize from one lung to the other lung.
The two main types of lung cancer, NSCLC and SCLC, metastasize to different sites at different rates. Subtypes of these lung cancers also metastasize to certain tissues.
According to oncology research, between 22 percent and 34 percent of people with NSCLC have metastases in their bones. SCLC metastasizes to the bones in around 13 percent of cases. The bones that are most likely to be affected include the spine, ribs, hip bone, and thigh bone. Bone metastases often cause additional health problems and reduced quality of life.
Symptoms of bone metastases include pain and broken bones or fractures.
Among people with NSCLC, 15 percent to 28 percent have brain metastases when diagnosed. SCLC metastasizes to the brain in about 14 percent of cases at the time of the first diagnosis. Throughout the disease, more than 80 percent of cases of SCLC metastasize to the brain.
Younger people may be slightly more likely to develop brain metastases. When lung cancer metastasizes to the brain, the outlook may be poor. People with brain metastases live for an average of six months after being diagnosed. Symptoms may include headache, nausea, dizziness, and seizures.
People with NSCLC develop adrenal gland metastases about 17 percent to 37 percent of the time. Around 1 out of 5 people with SCLC have adrenal gland metastases. People with adrenal gland metastases tend to be younger than those without metastases in this area.
Adenocarcinoma, a type of NSCLC, is more likely to metastasize to the adrenal glands than other types of lung cancer. Large cell carcinoma also frequently metastasizes in the adrenal glands. People with NSCLC who have adrenal gland metastases have a worse outlook than those with NSCLC whose cancer has not spread to the adrenal glands.
Symptoms of adrenal metastases include unexplained weight loss and anorexia, nausea and vomiting, abdominal pain, fatigue, confusion, and fever.
Liver metastasis is not as common for people with NSCLC. Around 6 percent to 13 percent of people with this type of cancer have lung cancer cells in the liver. On the other hand, SCLC is more likely to metastasize to the liver than to any other site. Between 24 percent and 35 percent of people with SCLC have liver metastases. People with NSCLC or SCLC who have liver metastases often have a poor outlook.
Liver metastases can cause symptoms such as abdominal swelling and jaundice — yellowing of eyes, dark urine, and lighter-colored stool.
Less commonly, lung cancer can also spread to other organs or tissues. Metastases may be found in the:
For people with NSCLC, lung tumors spread to the other lung about 20 percent to 32 percent of the time. About 8 percent of people with SCLC have tumors in both lungs. People with lung metastases tend to have better survival rates than those with metastases to more distant locations. Symptoms of lung metastases include coughing (sometimes with blood), chest pain, shortness of breath, and weight loss.
Metastatic lung cancer is an advanced form of lung cancer that has spread to other parts of the body, making it more difficult to treat. It’s often hard to detect early because symptoms usually show up after the cancer has spread. If you or someone you know has symptoms or a diagnosis of metastatic lung cancer, talk to your doctor to learn about treatment options and get support.
MyLungCancerTeam is the social network for people with lung cancer and their loved ones. On MyLungCancerTeam, more than 13,000 members come together to ask questions, give advice, and share their stories with others who understand life with lung cancer.
Are you living with metastatic lung cancer? Share your experience in the comments below, or start a conversation by posting on your Activities page.
Get updates directly to your inbox.
What Does It Means When You Have New Metabolically Active Left Adrenal Metastasis On A Pet Scan And You Have Lung Cancer
Become a member to get even more:
A MyLungCancerTeam Member
Thank you for sharing
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.